drugset / Trial / NCT00219050

A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension

NCT00219050

Phase 3 Completed 180 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the safety and efficacy of an aliskiren-based regimen to a lisinopril-based regimen in the treatment of severe hypertension

Timeline

Start
2005-02
Primary completion
2005-11
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Aliskiren Small molecule

Indications